Scavenger receptors in homeostasis and immunity (original) (raw)

• Brown, M. S. & Goldstein, J. L. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc. Natl Acad. Sci. USA 76, 3330–3337 (1979).
  CAS PubMed PubMed Central Google Scholar
• Brown, M. S., Goldstein, J. L., Krieger, M., Ho, Y. K. & Anderson, R. G. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J. Cell Biol. 82, 597–613 (1979).
  CAS PubMed Google Scholar
• Greaves, D. R. & Gordon, S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J. Lipid Res. 50, S282–S286 (2008).
  PubMed Google Scholar
• Kzhyshkowska, J., Neyen, C. & Gordon, S. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 217, 492–502 (2012).
  CAS PubMed Google Scholar
• Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nature Immunol. 12, 204–212 (2011).
  CAS Google Scholar
• Moore, Kathryn, J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341–355 (2011).
  CAS PubMed PubMed Central Google Scholar
• Tabas, I., Williams, K. J. & Borén, J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116, 1832–1844 (2007).
  CAS PubMed Google Scholar
• Miller, Y. I. et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108, 235–248 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hartvigsen, K. et al. The role of innate immunity in atherogenesis. J. Lipid Res. 50, S388–S393 (2008). In this study, the authors introduce the idea that oxidation-specific epitopes are DAMPs, which are major targets of many innate PRRs.
  PubMed Google Scholar
• Shibata, M. et al. Type F scavenger receptor SREC-I interacts with advillin, a member of the gelsolin/villin family, and induces neurite-like outgrowth. J. Biol. Chem. 279, 40084–40090 (2004).
  CAS PubMed Google Scholar
• Kzhyshkowska, J., Gratchev, A. & Goerdt, S. Stabilin-1, a homeostatic scavenger receptor with multiple functions. J. Cell. Mol. Med. 10, 635–649 (2006).
  CAS PubMed Google Scholar
• Gu, B. J., Saunders, B. M., Petrou, S. & Wiley, J. S. P2X7 is a scavenger receptor for apoptotic cells in the absence of its ligand, extracellular ATP. J. Immunol. 187, 2365–2375 (2011).
  CAS PubMed Google Scholar
• Bonventre, J. V. & Yang, L. Kidney injury molecule-1. Curr. Opin. Crit. Care 16, 556–561 (2010).
  PubMed Google Scholar
• Van Gorp, H., Delputte, P. L. & Nauwynck, H. J. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol. Immunol. 47, 1650–1660 (2010).
  CAS PubMed Google Scholar
• Areschoug, T., Gordon, S., Egesten, A., Schmidt, A. & Herwald, H. in Contributions to microbiology 45–60 (Karger, 2008).
  Google Scholar
• Plüddemann, A., Mukhopadhyay, S. & Gordon, S. The interaction of macrophage receptors with bacterial ligands. Expert Rev. Mol. Med. 8, 1–25 (2006).
  PubMed Google Scholar
• Plüddemann, A., Mukhopadhyay, S. & Gordon, S. Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry. Immunol. Rev. 240, 11–24 (2011).
  PubMed Google Scholar
• Krieger, M. The other side of scavenger receptors: pattern recognition for host defense. Curr. Opin. Lipidol. 8, 275–280 (1997).
  CAS PubMed Google Scholar
• Medzhitov, R. & Janeway, C. A. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298–300 (2002).
  CAS PubMed Google Scholar
• Mukhopadhyay, S., Plüddemann, A., Gordon, S. & Kishore, U. in Target pattern recognition in innate immunity 1–14 (Springer New York, 2009).
  Google Scholar
• Areschoug, T. & Gordon, S. Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell. Microbiol. 11, 1160–1169 (2009).
  CAS PubMed Google Scholar
• Mukhopadhyay, S. & Gordon, S. The role of scavenger receptors in pathogen recognition and innate immunity. Immunobiology 209, 39–49 (2004).
  CAS PubMed Google Scholar
• Plüddemann, A., Neyen, C. & Gordon, S. Macrophage scavenger receptors and host-derived ligands. Methods 43, 207–217 (2007).
  PubMed Google Scholar
• Suzuki, H. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292–296 (1997). This study shows that scavenger receptors — in particular SR-A1 — have an important role not only in host defence against pathogens but also in contributing to the generation of atherosclerotic lesions in vivo.
  CAS PubMed Google Scholar
• Taylor, P. R. et al. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23, 901–944 (2005).
  CAS PubMed Google Scholar
• Herrmann, M. et al. Clearance of fetuin-A−-containing calciprotein particles is mediated by scavenger receptor-A. Circ. Res. 111, 575–584 (2012).
  CAS PubMed Google Scholar
• Sun, M. et al. Light-induced oxidation of photoreceptor outer segment phospholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential mechanism for modulating outer segment phagocytosis under oxidant stress conditions. J. Biol. Chem. 281, 4222–4230 (2006).
  CAS PubMed Google Scholar
• Palani, S. et al. Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages. Eur. J. Immunol. 41, 2052–2063 (2011).
  CAS PubMed Google Scholar
• Shimaoka, T. et al. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J. Leukoc. Biol. 75, 267–274 (2004).
  CAS PubMed Google Scholar
• Santiago-Garcia, J., Kodama, T. & Pitas, R. The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J. Biol. Chem. 278, 6942–6946 (2003).
  CAS PubMed Google Scholar
• Murshid, A., Gong, J., Calderwood, S. K., Henderson, B. & Pockley, A. G. in Cellular trafficking of cell stress proteins in health and disease 215–227 (Springer Netherlands, 2012).
  Google Scholar
• Feng, H. et al. Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler. Thromb. Vasc. Biol. 31, 2543–2551 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kzhyshkowska, J. Multifunctional receptor stabilin-1 in homeostasis and disease. Scientific World Journal 10, 2039–2053 (2010).
  CAS PubMed PubMed Central Google Scholar
• Park, L. et al. Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc. Natl Acad. Sci. USA 110, 3089–3094 (2013).
  PubMed PubMed Central Google Scholar
• Podrez, E. A. et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nature Med. 13, 1086–1095 (2007).
  CAS PubMed Google Scholar
• Silverstein, R. L. & Febbraio, M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci. Signal. 2, re3 (2009).
  PubMed PubMed Central Google Scholar
• Wiley, J. S., Sluyter, R., Gu, B. J., Stokes, L. & Fuller, S. J. The human P2X7 receptor and its role in innate immunity. Tissue Antigens 78, 321–332 (2011).
  CAS PubMed Google Scholar
• Pal, S., Wu, L. & Kishore, U. Lessons from the fly: pattern recognition in Drosophila melanogaster. Target Pattern Recogn. Innate Immun. 653, 162–174 (2009).
  CAS Google Scholar
• Stuart, L. M. & Ezekowitz, R. A. Phagocytosis and comparative innate immunity: learning on the fly. Nature Rev. Immunol. 8, 131–141 (2008).
  CAS Google Scholar
• Cherry, S. & Silverman, N. Host-pathogen interactions in drosophila: new tricks from an old friend. Nature Immunol. 7, 911–917 (2006).
  CAS Google Scholar
• Song, L., Lee, C. & Schindler, C. Deletion of the murine scavenger receptor CD68. J. Lipid Res. 52, 1542–1550 (2011).
  CAS PubMed PubMed Central Google Scholar
• Fabriek, B. O. et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 113, 887–892 (2009).
  CAS PubMed Google Scholar
• Murphy, J. E., Tedbury, P. R., Homer-Vanniasinkam, S., Walker, J. H. & Ponnambalam, S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182, 1–15 (2005).
  CAS PubMed Google Scholar
• Sheikine, Y. & Sirsjö, A. CXCL16/SR-PSOX — A friend or a foe in atherosclerosis? Atherosclerosis 197, 487–495 (2008).
  CAS PubMed Google Scholar
• Sarrias, M.-R. et al. CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock. Proc. Natl Acad. Sci. USA 104, 11724–11729 (2007).
  CAS PubMed PubMed Central Google Scholar
• Vera, J. et al. The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome. Proc. Natl Acad. Sci. USA 106, 1506–1511 (2009).
  CAS PubMed PubMed Central Google Scholar
• Ichimura, T. et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118, 1657–1668 (2008).
  CAS PubMed PubMed Central Google Scholar
• Gu, B. J. et al. P2X7 receptor-mediated scavenger activity of mononuclear phagocytes toward non-opsonized particles and apoptotic cells is inhibited by serum glycoproteins but remains active in cerebrospinal fluid. J. Biol. Chem. 287, 17318–17330 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wiley, J. S. & Gu, B. J. A new role for the P2X7 receptor: a scavenger receptor for bacteria and apoptotic cells in the absence of serum and extracellular ATP. Purinerg. Signal 8, 579–586 (2012).
  CAS Google Scholar
• Ojala, J. R. M., Pikkarainen, T., Tuuttila, A., Sandalova, T. & Tryggvason, K. Crystal structure of the cysteine-rich domain of scavenger receptor, MARCO reveals the presence of a basic and an acidic cluster that both contribute to ligand recognition. J. Biol. Chem. 282, 16654–16666 (2007).
  CAS PubMed Google Scholar
• Rodamilans, B. et al. Crystal structure of the third extracellular domain of CD5 reveals the fold of a group B scavenger cysteine-rich receptor domain. J. Biol. Chem. 282, 12669–12677 (2007).
  CAS PubMed Google Scholar
• Ohki, I. et al. Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL. Structure 13, 905–917 (2005). This structural analysis was the first to identify basic features of the ligand-recognition surface of a scavenger receptor (in this case, LOX1), which has an essential role in oxLDL binding.
  CAS PubMed Google Scholar
• Park, H., Adsit, F. G. & Boyington, J. C. The 1.4 angstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1. J. Biol. Chem. 280, 13593–13599 (2005).
  CAS PubMed Google Scholar
• Feinberg, H., Taylor, M. E. & Weis, W. I. Scavenger receptor C-type lectin binds to the leukocyte cell surface glycan Lewisx by a novel mechanism. J. Biol. Chem. 282, 17250–17258 (2007).
  CAS PubMed Google Scholar
• Wilke, S., Krausze, J. & Büssow, K. Crystal structure of the conserved domain of the DC lysosomal associated membrane protein: implications for the lysosomal glycocalyx. BMC Biol. 10, 62 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kar, N. S., Ashraf, M. Z., Valiyaveettil, M. & Podrez, E. A. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36. J. Biol. Chem. 283, 8765–8771 (2008).
  CAS PubMed PubMed Central Google Scholar
• Shimaoka, T. et al. Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain. J. Biol. Chem. 279, 26807–26810 (2004).
  CAS PubMed Google Scholar
• Andersson, L. & Freeman, M. Functional changes in scavenger receptor binding conformation are induced by charge mutants spanning the entire collagen domain. J. Biol. Chem. 273, 19592–19601 (1998).
  CAS PubMed Google Scholar
• Kodama, T. et al. Collagenous macrophage scavenger receptors. Curr. Opin. Lipidol. 7, 287–291 (1996).
  CAS PubMed Google Scholar
• Podrez, E. A. et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105, 1095–1108 (2000).
  CAS PubMed PubMed Central Google Scholar
• Boullier, A. et al. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J. Biol. Chem. 275, 9163–9169 (2000).
  CAS PubMed Google Scholar
• Nicholson, A. C., Frieda, S., Pearce, A. & Silverstein, R. L. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler. Thromb. Vasc. Biol. 15, 269–275 (1995).
  CAS PubMed Google Scholar
• Rigotti, A., Acton, S. L. & Krieger, M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270, 16221–16224 (1995).
  CAS PubMed Google Scholar
• Ryeom, S. W., Silverstein, R. L., Scotto, A. & Sparrow, J. R. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J. Biol. Chem. 271, 20536–20539 (1996).
  CAS PubMed Google Scholar
• Podrez, E. A. et al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277, 38503–38516 (2002).
  CAS PubMed Google Scholar
• Podrez, E. A. et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277, 38517–38523 (2002).
  CAS PubMed Google Scholar
• Greenberg, M. E. et al. Oxidized phosphatidylserine- CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203, 2613–2625 (2006).
  CAS PubMed PubMed Central Google Scholar
• Gaidukov, L., Nager, A. R., Xu, S., Penman, M. & Krieger, M. Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport. J. Biol. Chem. 286, 18452–18464 (2011).
  CAS PubMed PubMed Central Google Scholar
• Reaven, E., Cortez, Y., Leers-Sucheta, S., Nomoto, A. & Azhar, S. Dimerization of the scavenger receptor class B type I formation, function, and localization in diverse cells and tissues. J. Lipid Res. 45, 513–528 (2004).
  CAS PubMed Google Scholar
• Sankala, M. et al. Characterization of recombinant soluble macrophage scavenger receptor MARCO. J. Biol. Chem. 277, 33378–33385 (2002).
  CAS PubMed Google Scholar
• Rahaman, S. O. et al. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell. Metab. 4, 211–221 (2006).
  CAS PubMed PubMed Central Google Scholar
• Bull, H. A., Brickell, P. M. & Dowd, P. M. Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett. 351, 41–44 (1994).
  CAS PubMed Google Scholar
• Huang, M. M., Bolen, J. B., Barnwell, J. W., Shattil, S. J. & Brugge, J. S. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc. Natl Acad. Sci. USA 88, 7844–7848 (1991).
  CAS PubMed PubMed Central Google Scholar
• Jiménez, B. et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nature Med. 6, 41–48 (2000).
  PubMed Google Scholar
• Shaw, A. S. et al. Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase. Mol. Cell. Biol. 10, 1853–1862 (1990).
  CAS PubMed PubMed Central Google Scholar
• Turner, J. M. et al. Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60, 755–765 (1990).
  CAS PubMed Google Scholar
• Moore, K. J. et al. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 277, 47373–47379 (2002). This is the initial report of a pro-inflammatory role of CD36 induced by β-amyloid.
  CAS PubMed Google Scholar
• Medeiros, L. A. et al. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J. Biol. Chem. 279, 10643–10648 (2004).
  CAS PubMed Google Scholar
• Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunol. 11, 155–161 (2010). This study establishes that the assembly of the TLR4–TLR6 heterodimer is regulated by CD36 and that signals from the CD36–TLR4–TLR6 complex characterize the mechanism by which atherogenic lipids and β-amyloid trigger sterile inflammation.
  CAS Google Scholar
• Calzada, M. J. et al. Identification of novel β1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1. J. Biol. Chem. 279, 41734–41743 (2004).
  CAS PubMed Google Scholar
• Chang, Y. & Finnemann, S. C. Tetraspanin CD81 is required for the αvβ5-integrin-dependent particle-binding step of RPE phagocytosis. J. Cell Sci. 120, 3053–3063 (2007).
  CAS PubMed Google Scholar
• Heit, B. et al. Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization. Dev. Cell 24, 372–383 (2013).
  CAS PubMed PubMed Central Google Scholar
• Todt, J. C., Hu, B. & Curtis, J. L. The scavenger receptor SR-A I/II (CD204) signals via the receptor tyrosine kinase Mertk during apoptotic cell uptake by murine macrophages. J. Leukoc. Biol. 84, 510–518 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yu, H. et al. Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-κB activation in macrophages. Biochim. Biophys. Acta 1823, 1192–1198 (2012).
  CAS PubMed PubMed Central Google Scholar
• Mukhopadhyay, S. et al. SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 117, 1319–1328 (2011).
  CAS PubMed Google Scholar
• Triantafilou, M. et al. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281, 31002–31011 (2006).
  CAS PubMed Google Scholar
• Erdman, L. K. et al. CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria. J. Immunol. 183, 6452–6459 (2009).
  CAS PubMed Google Scholar
• Pupovac, A., Foster, C. M. & Sluyter, R. Human P2X7 receptor activation induces the rapid shedding of CXCL16. Biochem. Biophys. Res. Commun. 432, 626–631 (2013).
  CAS PubMed Google Scholar
• Gu, X. et al. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by Its extracellular domain. J. Biol. Chem. 273, 26338–26348 (1998).
  CAS PubMed Google Scholar
• Rigotti, A., Miettinen, H. E. & Krieger, M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other Ttissues. Endocr. Rev. 24, 357–387 (2003).
  CAS PubMed Google Scholar
• Chroni, A., Nieland, T. J. F., Kypreos, K. E., Krieger, M. & Zannis, V. I. SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry 44, 13132–13143 (2005).
  CAS PubMed Google Scholar
• Nieland, T. J. F., Xu, S., Penman, M. & Krieger, M. Negatively cooperative binding of high-density lipoprotein to the HDL. receptor SR-BI. Biochemistry 50, 1818–1830 (2011).
  CAS PubMed Google Scholar
• Su, X. & Abumrad, N. A. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol. Metabol. 20, 72–77 (2009).
  CAS Google Scholar
• Kennedy, D. J. & Kashyap, S. R. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes. Metab. Syndr. Relat. Disord. 9, 239–245 (2011).
  CAS PubMed Google Scholar
• Martin, C. et al. CD36 as a lipid sensor. Physiol. Behav. 105, 36–42 (2011).
  CAS PubMed Google Scholar
• Martin, C. et al. The lipid-sensor candidates CD36 and GPR120 are differentially regulated by dietary lipids in mouse taste buds: impact on spontaneous fat preference. PLoS ONE 6, e24014 (2011).
  CAS PubMed PubMed Central Google Scholar
• Pepino, M. Y., Love-Gregory, L., Klein, S. & Abumrad, N. A. The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects. J. Lipid Res. 53, 561–566 (2012).
  CAS PubMed PubMed Central Google Scholar
• Helming, L., Winter, J. & Gordon, S. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J. Cell Sci. 122, 453–459 (2009).
  CAS PubMed PubMed Central Google Scholar
• Anderson, J. M. Multinucleated giant cells. Curr. Opin. Hematol. 7, 40–47 (2000).
  CAS PubMed Google Scholar
• Byrd, T. F. Multinucleated giant cell formation induced by IFN-γ/IL-3 is associated with restriction of virulent Mycobacterium tuberculosis cell to cell invasion in human monocyte monolayers. Cell. Immunol. 188, 89–96 (1998).
  CAS PubMed Google Scholar
• Reczek, D. et al. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of β-glucocerebrosidase. Cell 131, 770–783 (2007).
  CAS PubMed Google Scholar
• Blanz, J. et al. Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand β-glucocerebrosidase. Hum. Mol. Genet. 19, 563–572 (2010).
  CAS PubMed Google Scholar
• Desmond, M. J. et al. Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2. Am. J. Physiol. Renal Physiol. 300, F1437–F1447 (2011).
  CAS PubMed Google Scholar
• Etzerodt, A. & Moestrup, S. K. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid. Redox Signal. 18, 2352–2363 (2012).
  PubMed Google Scholar
• Braun, M. et al. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion. J. Innate Immun. 3, 420–434 (2011).
  CAS PubMed Google Scholar
• Abel, S. et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-γ and TNF-α and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172, 6362–6372 (2004).
  CAS PubMed Google Scholar
• Burdo, T. H. et al. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J. Infect. Dis. 204, 154–163 (2011).
  CAS PubMed PubMed Central Google Scholar
• Madsen, M. et al. Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region. J. Biol. Chem. 279, 51561–51567 (2004).
  CAS PubMed Google Scholar
• Kristiansen, M. et al. Identification of the haemoglobin scavenger receptor. Nature 409, 198–201 (2001). This reference identifies CD163 as the receptor for the haptoglobin–haemoglobin complex, which provides a mechanism for haemoglobin clearance.
  CAS PubMed Google Scholar
• Alonso, R. et al. Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome. J. Autoimmun 35, 336–341 (2010).
  CAS PubMed Google Scholar
• Smith, E. R., Hanssen, E., McMahon, L. P. & Holt, S. G. Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage. PLoS ONE 8, e60904 (2013).
  CAS PubMed PubMed Central Google Scholar
• Chen, Y. et al. Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A. J. Immunol. 175, 8173–8180 (2005).
  CAS PubMed Google Scholar
• Karlsson, M. C. et al. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198, 333–340 (2003).
  CAS PubMed PubMed Central Google Scholar
• Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nature Rev. Immunol. 8, 958–969 (2008).
  CAS Google Scholar
• Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A. & Locati, M. Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 229, 176–185 (2013).
  CAS PubMed Google Scholar
• Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787–795 (2012).
  CAS PubMed PubMed Central Google Scholar
• Oh, J. et al. Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation. J. Biol. Chem. 287, 11629–11641 (2012).
  CAS PubMed PubMed Central Google Scholar
• Buechler, C. et al. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukoc. Biol. 67, 97–103 (2000).
  CAS PubMed Google Scholar
• Weaver, L. K., Pioli, P. A., Wardwell, K., Vogel, S. N. & Guyre, P. M. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors. J. Leukoc. Biol. 81, 663–671 (2007).
  CAS PubMed Google Scholar
• Xu, W. et al. Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. Eur. J. Immunol. 37, 1594–1599 (2007).
  CAS PubMed Google Scholar
• Tippett, E. et al. Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals. PloS ONE 6, e19968 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ogden, C. A. et al. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma. J. Immunol. 174, 3015–3023 (2005).
  CAS PubMed Google Scholar
• Xu, W. et al. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107, 4930–4937 (2006).
  CAS PubMed Google Scholar
• Zizzo, G., Hilliard, B. A., Monestier, M. & Cohen, P. L. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J. Immunol. 189, 3508–3520 (2012).
  CAS PubMed Google Scholar
• Fadok, V. A., Warner, M. L., Bratton, D. L. & Henson, P. M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (αvβ3). J. Immunol. 161, 6250–6257 (1998).
  CAS PubMed Google Scholar
• Bover, L. C. et al. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J. Immunol. 178, 8183–8194 (2007).
  CAS PubMed Google Scholar
• Schaer, D. J., Alayash, A. I. & Buehler, P. W. Gating the radical hemoglobin to macrophages: the anti-inflammatory role of CD163, a scavenger receptor. Antioxid. Redox Signal. 9, 991–999 (2007).
  CAS PubMed Google Scholar
• Philippidis, P. et al. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circul. Res. 94, 119–126 (2004).
  CAS Google Scholar
• Józefowski, S. & Kobzik, L. Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages. J. Leukoc.Biol. 76, 1066–1074 (2004). In this study the authors show that the scavenger receptors SR-A1 and MARCO are differentially regulated by M1-polarizing versus M2-polarizing factors. In addition, MARCO is shown to stimulate pro-inflammatory cytokine production, whereas SR-A1 has the opposite effect.
  PubMed Google Scholar
• Józefowski, S., Arredouani, M., Sulahian, T. & Kobzik, L. Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. J. Immunol. 175, 8032–8041 (2005). This study shows that the class B scavenger receptor CD36 is a selective sensor of microbial diacylated lipoproteins and LTA, which signal through the TLR2–TLR6 heterodimer.
  PubMed Google Scholar
• Hoebe, K. et al. CD36 is a sensor of diacylglycerides. Nature 433, 523–527 (2005).
  CAS PubMed Google Scholar
• Kennedy, D. J. et al. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc. Res. 89, 604–613 (2011).
  CAS PubMed Google Scholar
• Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549–555 (2002).
  CAS PubMed Google Scholar
• Mukhopadhyay, S. & Gordon, S. The role of scavenger receptors in pathogen recognition and innate immunity. Immunobiology 209, 39–49 (2004).
  CAS PubMed Google Scholar
• Peiser, L. et al. Identification of Neisseria meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger receptor by using a novel assay. Infect. Immun. 74, 5191–5199 (2006).
  CAS PubMed PubMed Central Google Scholar
• Thomas, C. A. et al. Protection from lethal Gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J. Exp. Med. 191, 147–156 (2000).
  CAS PubMed PubMed Central Google Scholar
• Peiser, L. et al. The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect. Immun. 70, 5346–5354 (2002).
  CAS PubMed PubMed Central Google Scholar
• Arredouani, M. S. et al. The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am. J. Respir. Cell. Mol. Biol. 35, 474–478 (2006). This study shows that SR-A1 and MARCO recognize overlapping but distinct sets of endogenous and microbial ligands, which highlights the fine specificities of two related scavenger receptors.
  CAS PubMed PubMed Central Google Scholar
• Plüddemann, A. et al. SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors. J. Innate Immun. 1, 153–163 (2009).
  PubMed Google Scholar
• Amiel, E. et al. Pivotal advance: Toll-like receptor regulation of scavenger receptor-A-mediated phagocytosis. J. Leukoc. Biol. 85, 595–605 (2009).
  CAS PubMed Google Scholar
• Bowdish, D. M. E. et al. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 5, e1000474 (2009).
  PubMed PubMed Central Google Scholar
• Dreux, M. et al. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog. 5, e1000310 (2009).
  PubMed PubMed Central Google Scholar
• Ploss, A. et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882–886 (2009).
  CAS PubMed PubMed Central Google Scholar
• Westhaus, S. et al. Characterization of the inhibition of hepatitis C virus entry by _in vitro_-generated and patient-derived oxidized low-density lipoprotein. Hepatology 57, 1716–1724 (2012).
  Google Scholar
• Dao Thi, V. L. et al. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. J. Biol. Chem. 287, 31242–31257 (2012).
  CAS PubMed PubMed Central Google Scholar
• Cox, J. V., Naher, N., Abdelrahman, Y. M. & Belland, R. J. Host HDL biogenesis machinery is recruited to the inclusion of _Chlamydia trachomatis_-infected cells and regulates chlamydial growth. Cell. Microbiol. 14, 1497–1512 (2012).
  CAS PubMed PubMed Central Google Scholar
• Yamayoshi, S. et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nature Med. 15, 798–801 (2009).
  CAS PubMed Google Scholar
• Yamayoshi, S. et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J. Virol. 86, 5686–5696 (2012).
  CAS PubMed PubMed Central Google Scholar
• Yamayoshi, S., Ohka, S., Fujii, K. & Koike, S. Functional Comparison of SCARB2 and PSGL1 as Receptors for Enterovirus 71. J. Virol. 87, 3335–3347 (2013).
  CAS PubMed PubMed Central Google Scholar
• Stuart, L. M. et al. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170, 477–485 (2005).
  CAS PubMed PubMed Central Google Scholar
• Baranova, I. N. et al. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J. Immunol. 181, 7147–7156 (2008).
  CAS PubMed Google Scholar
• Patel, S. N. et al. Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J. Immunol. 178, 3954–3961 (2007).
  CAS PubMed Google Scholar
• Philips, J. A., Rubin, E. J. & Perrimon, N. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309, 1251–1253 (2005).
  CAS PubMed Google Scholar
• Hawkes, M. et al. CD36 deficiency attenuates experimental mycobacterial infection. BMC Infect. Dis. 10, 299 (2010).
  PubMed PubMed Central Google Scholar
• Santiago-Garcia, J., Mas-Oliva, J., Innerarity, T. & Pitas, R. Secreted forms of the amyloid-β precursor protein are ligands for the class A scavenger receptor. J. Biol. Chem. 276, 30655–30661 (2001).
  CAS PubMed Google Scholar
• Park, L. et al. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β. Proc. Natl Acad. Sci. USA 108, 5063–5068 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hansson, G. K. Inflammatory mechanisms in atherosclerosis. J. Thromb. Haemost. 7, 328–331 (2009).
  CAS PubMed Google Scholar
• Yang, Z. & Ming, X.-F. CD36: the common soil for inflammation in obesity and atherosclerosis? Cardiovasc. Res. 89, 485–486 (2011).
  CAS PubMed Google Scholar
• van Berkel, T. J. C. et al. Scavenger receptors: friend or foe in atherosclerosis? Curr. Opin. Lipidol. 16, 525–535 (2005).
  CAS PubMed Google Scholar
• Moore, K. J. & Freeman, M. W. Scavenger receptors in atherosclerosis beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 26, 1702–1711 (2006).
  CAS PubMed Google Scholar
• Gautam, S. & Banerjee, M. The macrophage Ox-LDL receptor, CD36 and its association with type II diabetes mellitus. Mol. Genet. Metab. 102, 389–398 (2011).
  CAS PubMed Google Scholar
• Nosadini, R. & Tonolo, G. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 21, 79–85 (2011).
  CAS PubMed Google Scholar
• Wilkinson, K. & El Khoury, J. Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease. Int. J. Alzheimers Dis. 2012, 1–10 (2012).
  Google Scholar
• Yamanaka, M. et al. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. J. Neurosci. 32, 17321–17331 (2012).
  CAS PubMed PubMed Central Google Scholar
• Mathieu, P., Pibarot, P. & Després, J. P. Metabolic syndrome: the danger signal in atherosclerosis. Vasc. Health Risk Manag. 2, 285–302 (2006).
  CAS PubMed PubMed Central Google Scholar
• Tabas, I. Macrophage death and defective inflammation resolution in atherosclerosis. Nature Rev. Immunol. 10, 36–46 (2010).
  CAS Google Scholar
• Xu, S. et al. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell. Mol. Life Sci. 70, 2859–2872 (2013).
  CAS PubMed Google Scholar
• Silverstein, R. L., Li, W., Park, Y. M. & Rahaman, S. O. Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. Trans. Am. Clin. Climatol. Assoc. 121, 206–220 (2010).
  PubMed PubMed Central Google Scholar
• Mitra, S., Goyal, T. & Mehta, J. L. Oxidized LDL, LOX-1 and Atherosclerosis. Cardiovasc. Drugs Ther. 25, 419–429 (2011).
  CAS PubMed Google Scholar
• Kunjathoor, V. V. et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277, 49982–49988 (2002). This study shows the pro-atherogenic role of CD36 in vivo.
  CAS PubMed Google Scholar
• Sun, B. et al. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J. Lipid Res. 48, 2560–2570 (2007).
  CAS PubMed Google Scholar
• Kuchibhotla, S. et al. Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. Cardiovasc. Res. 78, 185–196 (2008).
  CAS PubMed Google Scholar
• Stewart, C. R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunol. 11, 155–161 (2010).
  CAS Google Scholar
• Sheedy, F. J. et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nature Immunol. 14, 812–820 (2013).
  CAS Google Scholar
• Björkbacka, H. et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nature Med. 10, 416–421 (2004).
  PubMed Google Scholar
• Michelsen, K. S. et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl Acad. Sci. USA 101, 10679–10684 (2004).
  CAS PubMed PubMed Central Google Scholar
• Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H. & Evans, R. M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93, 229–240 (1998).
  CAS PubMed Google Scholar
• Bujold, K. et al. CD36-mediated cholesterol efflux is associated with PPARγ activation via a MAPK-dependent COX-2 pathway in macrophages. Cardiovasc. Res. 83, 457–464 (2009).
  CAS PubMed Google Scholar
• Tontonoz, P., Nagy, L., Alvarez, J. G., Thomazy, V. A. & Evans, R. M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241–252 (1998).
  CAS PubMed Google Scholar
• Scull, C. M. & Tabas, I. Mechanisms of ER stress-induced apoptosis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 31, 2792–2797 (2011).
  CAS PubMed PubMed Central Google Scholar
• Tandon, N. N., Lipsky, R. H., Burgess, W. H. & Jamieson, G. A. Isolation and characterization of platelet glycoprotein IV (CD36). J. Biol. Chem. 264, 7570–7575 (1989).
  CAS PubMed Google Scholar
• Podrez, E. A. et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nature Med. 13, 1086–1095 (2007).
  CAS PubMed Google Scholar
• Rhainds, D. & Brissette, L. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking: Defining the rules for lipid traders. Int. J. Biochem. Cell Biol. 36, 39–77 (2004).
  CAS PubMed Google Scholar
• Carvalho, A. C., Colman, R. W. & Lees, R. S. Platelet function in hyperlipoproteinemia. N. Engl. J. Med. 290, 434–438 (1974). This report establishes SR-B1 as a bona fide HDL receptor.
  CAS PubMed Google Scholar
• Stuart, M. J., Gerrard, J. M. & White, J. G. Effect of cholesterol on production of thromboxane b2 by platelets in vitro. N. Engl. J. Med. 302, 6–10 (1980).
  CAS PubMed Google Scholar
• Davì, G. et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 97, 953–957 (1998).
  PubMed Google Scholar
• Davì, G. et al. Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation 85, 1792–1798 (1992).
  PubMed Google Scholar
• Ghosh, A. et al. Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. J. Clin. Invest. 118, 1934–1943 (2008).
  CAS PubMed PubMed Central Google Scholar
• Chen, M. et al. Activation-dependent surface expression of LOX-1 in human platelets. Biochem. Biophys. Res. Commun. 282, 153–158 (2001).
  CAS PubMed Google Scholar
• Marwali, M. R. et al. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J. Pharmacol. Exp. Ther. 322, 1324–1332 (2007).
  CAS PubMed Google Scholar
• Kozarsky, K. F., Donahee, M. H., Glick, J. M., Krieger, M. & Rader, D. J. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 20, 721–727 (2000).
  CAS PubMed Google Scholar
• Braun, A. et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ. Res. 90, 270–276 (2002).
  CAS PubMed Google Scholar
• Zhang, W. et al. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108, 2258–2263 (2003).
  CAS PubMed Google Scholar
• Mineo, C. & Shaul, P. W. Functions of scavenger receptor class B, type I in atherosclerosis. Curr. Opin. Lipidol 23, 487–493 (2012).
  CAS PubMed Google Scholar
• Imachi, H. et al. Expression of human scavenger receptor B1 on and in human platelets. Arterioscler. Thromb. Vasc. Biol. 23, 898–904 (2003).
  CAS PubMed Google Scholar
• Valiyaveettil, M. et al. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood 111, 1962–1971 (2008).
  CAS PubMed PubMed Central Google Scholar
• Acton, S. et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518–520 (1996).
  CAS PubMed Google Scholar
• Rosenson, R. S. et al. Cholesterol efflux and atheroprotection advancing the concept of reverse cholesterol transport. Circulation 125, 1905–1919 (2012).
  PubMed PubMed Central Google Scholar
• Chadwick, A. C. & Sahoo, D. Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks. Curr. Opin. Endocrinol. Diabetes Obes. 20, 124–131 (2013).
  CAS PubMed PubMed Central Google Scholar
• Rhainds, D. et al. Localization and regulation of SR-BI in membrane rafts of HepG2 cells. J. Cell Sci. 117, 3095–3105 (2004).
  CAS PubMed Google Scholar
• Silver, D. L. SR-BI and protein–protein interactions in hepatic high density lipoprotein metabolism. Rev. Endocr. Metab. Disord. 5, 327–333 (2004).
  CAS PubMed Google Scholar
• Yancey, P. G. et al. Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI. J. Lipid Res. 48, 1140–1149 (2007).
  CAS PubMed Google Scholar
• Manichaikul, A. et al. Association of SCARB1 variants with subclinical atherosclerosis and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 1991–1999 (2012).
  CAS PubMed PubMed Central Google Scholar
• Naj, A. C. et al. Association of scavenger receptor class B type I polymorphisms with subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Circ. Cardiovasc. Genet. 3, 47–52 (2010).
  CAS PubMed Google Scholar
• Aronow, W. S. Antiplatelet therapy in peripheral arterial disease. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4, 265–267 (2004).
  CAS PubMed Google Scholar
• Aslanian, A. M. & Charo, I. F. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114, 583–590 (2006).
  CAS PubMed Google Scholar
• Sakaguchi, H. et al. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab Invest. 78, 423–434 (1998).
  CAS PubMed Google Scholar
• Holland, W. L. et al. Lipid mediators of insulin resistance. Nutr. Rev. 65, S39–46 (2007).
  PubMed Google Scholar
• Holloway, G. P. et al. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am. J. Physiol. Endocrinol. Metab. 296, E738–E747 (2009).
  CAS PubMed Google Scholar
• Glatz, J. F., Luiken, J. J. & Bonen, A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 90, 367–417 (2010).
  CAS PubMed Google Scholar
• Bonen, A. et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18, 1144–1146 (2004).
  CAS PubMed Google Scholar
• Coort, S. L. M. et al. Sulfo-_N_-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol. Cell. Biochem. 239, 213–219 (2002).
  CAS PubMed Google Scholar
• Pelsers, M. M. et al. Skeletal muscle fatty acid transporter protein expression in type 2 diabetes patients compared with overweight, sedentary men and age-matched, endurance-trained cyclists. Acta Physiol. (Oxf.) 190, 209–219 (2007).
  CAS Google Scholar
• Bokor, S. et al. Single-nucleotide polymorphism of CD36 locus and obesity in European adolescents. Obesity (Silver Spring) 18, 1398–1403 (2010).
  CAS Google Scholar
• Heni, M. et al. Variants in the CD36 gene locus determine whole-body adiposity, but have no independent effect on insulin sensitivity. Obesity (Silver Spring) 19, 1004–1009 (2011).
  CAS Google Scholar
• Love-Gregory, L. et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum. Mol. Genet. 17, 1695–1704 (2008).
  CAS PubMed PubMed Central Google Scholar
• Leprêtre, F., Cheyssac, C., Amouyel, P., Froguel, P. & Helbecque, N. A promoter polymorphism in CD36 is associated with an atherogenic lipid profile in a French general population. Atherosclerosis 173, 375–377 (2004).
  PubMed Google Scholar
• Ma, X. et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum. Mol. Genet. 13, 2197–2205 (2004).
  CAS PubMed Google Scholar
• Leprêtre, F. et al. Genetic study of the CD36 gene in a French diabetic population. Diabetes Metab. 30, 459–463 (2004).
  PubMed Google Scholar
• Corpeleijn, E. et al. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance. Diabet. Med. 23, 907–911 (2006).
  CAS PubMed Google Scholar
• Alkhatatbeh, M. J., Enjeti, A. K., Acharya, S., Thorne, R. F. & Lincz, L. F. The origin of circulating CD36 in type 2 diabetes. Nutr. Diabetes 3, e59 (2013).
  CAS PubMed PubMed Central Google Scholar
• Zhu, W., Li, W. & Silverstein, R. L. Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36. Blood 119, 6136–6144 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ghosh, A. et al. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood 117, 6355–6366 (2011).
  CAS PubMed PubMed Central Google Scholar
• Heneka, M. T. & O'Banion, M. K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184, 69–91 (2007).
  CAS PubMed Google Scholar
• Chung, H., Brazil, M. I., Irizarry, M. C., Hyman, B. T. & Maxfield, F. R. Uptake of fibrillar β-amyloid by microglia isolated from MSR-A (type I and type II) knockout mice. Neuroreport 12, 1151–1154 (2001).
  CAS PubMed Google Scholar
• El Khoury, J. B. et al. CD36 mediates the innate host response to β-amyloid. J. Exp. Med. 197, 1657–1666 (2003).
  CAS PubMed PubMed Central Google Scholar